IBKR

Interactive Brokers

$81.35

-2.96%
May 22, 2026
Bobby Quantitative Model
Interactive Brokers Group, Inc. is a leading automated global electronic broker, providing sophisticated trading platforms and services for retail and institutional clients across more than 170 electronic exchanges in over 40 countries. The company has established a distinct competitive identity as a low-cost, technology-driven platform catering to a sophisticated audience of active traders, hedge funds, and introducing brokers, with over 80% of its active accounts based outside the US. The current investor narrative is driven by its direct exposure to increased global trading activity and market volatility, as highlighted by recent news positioning it as a beneficiary of market uncertainty, alongside ongoing industry catalysts such as regulatory changes and the growth of prediction markets.

People also watch

Strive, Inc. Variable Rate Series A Perpetual Preferred Stock

Strive, Inc. Variable Rate Series A Perpetual Preferred Stock

SATA

Analysis
Fundrise Innovation Fund, LLC

Fundrise Innovation Fund, LLC

VCX

Analysis
Berkshire Hathaway Inc.

Berkshire Hathaway Inc.

BRK-B

Analysis
JPMorgan Chase

JPMorgan Chase

JPM

Analysis
Visa Inc.

Visa Inc.

V

Analysis

BobbyInvestment Opinion: Should I buy IBKR Today?

Rating & Thesis: Hold. IBKR is a high-quality, efficiently-run growth compounder trading at a full valuation that prices in near-perfect execution, making the risk/reward balanced at current levels. The lack of a clear analyst consensus underscores the need for investor caution despite the strong fundamental story.

Supporting Evidence: The Hold rating is supported by four key data points: 1) The stock's trailing P/E of 29.11x is at the peak of its historical range, suggesting limited multiple expansion potential. 2) Revenue growth is robust at 13.55% YoY, but must be sustained to justify the premium. 3) Profitability is best-in-class with an 87.52% operating margin. 4) The technical picture shows the stock is extended, trading at 92% of its 52-week high after a 57% yearly run, increasing near-term pullback risk.

Risks & Conditions: The two biggest risks are valuation compression and a slowdown in revenue growth momentum, as evidenced by the recent Q1 revenue miss. This Hold would upgrade to a Buy if the P/E multiple corrects meaningfully below 25x without a deterioration in the growth profile, or if revenue growth accelerates sustainably above 15%. It would downgrade to a Sell if quarterly revenue growth decelerates below 10% or operating margins contract significantly. Relative to its own history and sector, the stock is currently fairly valued to slightly overvalued, demanding flawless execution.

Sign up to view all

IBKR 12-Month Price Forecast

IBKR presents a classic 'high-quality, fully-valued' investment profile. The fundamentals are undeniably strong, with best-in-class efficiency and robust growth. However, the market has fully appreciated this, baking perfection into a 29x P/E multiple at the top of the stock's historical range. The neutral stance reflects this balance: the quality argues against a Sell, but the valuation and technical overextension argue against an aggressive Buy. The stance would upgrade to Bullish on a meaningful pullback (toward $70-$75) that improves the risk/reward, or if revenue growth sustainably accelerates. It would downgrade to Bearish on concrete signs of growth deceleration or margin contraction.

Historical Price
Current Price $81.35
Average Target $85
High Target $105
Low Target $55

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Interactive Brokers's 12-month outlook, with a consensus price target around $105.75 and implied upside of +30.0% versus the current price.

Average Target

$105.75

1 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

1

covering this stock

Price Range

$65 - $106

Analyst target range

Buy
0 (0%)
Hold
0 (0%)
Sell
1 (100%)

Insufficient analyst coverage available. The provided data indicates coverage from only one analyst, which is minimal for a company of this market cap. This limited coverage typically implies the stock is under-followed by the broader sell-side community, which can lead to higher volatility and less efficient price discovery. The lack of a consensus target price or rating distribution prevents a meaningful assessment of analyst sentiment, placing greater onus on investors to conduct independent fundamental and valuation analysis.

Drowning in data?

Find the real signal!

Bulls vs Bears: IBKR Investment Factors

The bullish case for IBKR, anchored in its exceptional operational efficiency, accelerating revenue growth, and pristine balance sheet, currently holds stronger evidence. The bear case primarily revolves around valuation risk, with the stock trading at peak historical multiples. The single most important tension in the investment debate is whether the company's industry-leading 87.5% operating margins and 13.6% revenue growth can sustainably justify a 29x P/E multiple that is at the top of its historical range and a premium to its sector. The resolution of this tension—through either sustained execution that grows into the valuation or a growth stumble that triggers multiple compression—will dictate the stock's direction.

Bullish

  • Exceptional Profitability & Efficiency: The company's operating model is incredibly efficient, with Q4 2025 operating margins of 87.52% and gross margins of 91.12%. This structural advantage, driven by its automated platform, provides a massive competitive moat and superior cash generation compared to traditional brokers.
  • Robust & Accelerating Revenue Growth: Revenue growth is strong and improving, with Q4 2025 revenue of $2.749 billion representing a 13.55% year-over-year increase. The sequential quarterly trend from $2.31B in Q1 to $2.749B in Q4 demonstrates consistent top-line momentum, driven by global client adoption and market activity.
  • Outstanding Financial Health & Cash Flow: IBKR has a fortress balance sheet with a negligible debt-to-equity ratio of 0.0035 and a robust current ratio of 1.13. Most impressively, it generates massive free cash flow, with TTM FCF of $15.744 billion, providing immense flexibility for growth and shareholder returns without financial risk.
  • Strong Technical Momentum & Relative Strength: The stock has significantly outperformed the market, with a 1-year price change of +57.41% vs. SPY's +27.88%. Its 3-month gain of +9.35% also outpaces the market's +8.15%, confirming sustained relative strength and investor confidence in its growth narrative.

Bearish

  • Peak Valuation Relative to History: The stock trades at a trailing P/E of 29.11x, which is at the top of its own multi-year historical range (approximately 13x to 29x). This peak valuation leaves little room for error and suggests the market has priced in highly optimistic expectations for future growth.
  • Elevated Volatility & Proximity to Highs: With a beta of 1.322, the stock is 32% more volatile than the market. Currently trading at 92% of its 52-week range ($81.35 vs. a high of $88.44), it is vulnerable to a technical pullback if momentum falters, especially after its 57% yearly run-up.
  • Revenue Miss Demonstrates Execution Risk: Recent news indicates the stock declined after a Q1 2026 revenue miss, despite meeting earnings targets. This event highlights the execution risk and the market's heightened sensitivity to any deviation from growth expectations at current valuation levels.
  • Limited Analyst Coverage & Sentiment: The stock suffers from minimal sell-side analyst coverage, with data from only one analyst. This lack of coverage can lead to less efficient price discovery, higher volatility, and a reduced institutional following, which may cap multiple expansion.

IBKR Technical Analysis

The stock is in a sustained and powerful uptrend, evidenced by a 1-year price change of +57.41%, significantly outperforming the SPY's +27.88% gain. As of the latest close at $81.35, the price is trading at approximately 92% of its 52-week range ($49.15 to $88.44), positioning it near its all-time highs, which signals strong momentum but also raises concerns about potential overextension. Recent momentum shows acceleration, with a 3-month gain of +9.35% and a 1-month gain of +4.15%, both outpacing the broader market's respective gains of +8.15% and +4.84%, indicating the stock's relative strength is intact despite the elevated level. The stock's beta of 1.322 confirms it is approximately 32% more volatile than the market, a critical factor for risk management, especially given its proximity to the key resistance level at the 52-week high of $88.44; a decisive breakout above this level would signal a continuation of the bullish trend, while a failure could lead to a pullback toward the primary support area near the 52-week low.

Beta

1.32

1.32x market volatility

Max Drawdown

-18.8%

Largest decline past year

52-Week Range

$49-$88

Price range past year

Annual Return

+57.4%

Cumulative gain past year

PeriodIBKR ReturnS&P 500
1m+4.1%+4.4%
3m+9.3%+9.3%
6m+33.3%+10.5%
1y+57.4%+28.8%
ytd+21.0%+9.3%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

IBKR Fundamental Analysis

Revenue growth is robust and accelerating, with Q4 2025 revenue of $2.749 billion representing a 13.55% year-over-year increase, and a sequential quarterly trend showing consistent growth from $2.31 billion in Q1 to $2.749 billion in Q4. The company is highly profitable, reporting Q4 net income of $284 million and a gross margin of 91.12%, with operating margins remaining exceptionally strong at 87.52%, reflecting the efficiency of its automated platform model. Financial health is outstanding, characterized by a negligible debt-to-equity ratio of 0.0035, a robust current ratio of 1.13, and massive free cash flow generation, with TTM free cash flow of $15.744 billion, providing ample internal resources to fund growth and return capital to shareholders without reliance on external financing.

Quarterly Revenue

$2.7B

2025-12

Revenue YoY Growth

+0.13%

YoY Comparison

Gross Margin

+0.91%

Latest Quarter

Free Cash Flow

$15.7B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Commissions
Market Data Fees
Others
Payments For Order Flow
Risk Exposure Fees

Open an Account, get $2 TSLA now!

Valuation Analysis: Is IBKR Overvalued?

Given a positive net income of $284 million, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 29.11x and a forward PE of 28.49x, with the minimal gap between the two suggesting the market expects steady, rather than accelerating, earnings growth in the near term. Compared to sector averages, the valuation appears elevated; for instance, the trailing PE of 29.11x is above typical financial services multiples, though this premium is likely justified by IBKR's superior growth profile, industry-leading margins, and asset-light platform model compared to traditional banks. Historically, the current trailing PE of 29.11x is near the top of its own multi-year range, which has fluctuated between approximately 13x and 29x over recent years, indicating the stock is pricing in optimistic expectations and trading at a peak valuation level relative to its own history.

PE

29.1x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 14x~36x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

11.7x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: IBKR's primary financial risk is not leverage or liquidity—its debt-to-equity of 0.0035 and $15.7B TTM FCF are stellar—but rather earnings volatility and concentration. Net income margin, while positive at 9.6%, can fluctuate quarter-to-quarter as seen in the sequential results. The business model's revenue is heavily tied to net interest income and customer trading commissions, making it sensitive to interest rate changes and market volatility cycles. A sustained period of low volatility and declining rates could pressure the 13.6% YoY revenue growth that currently supports the valuation.

Market & Competitive Risks: The paramount market risk is valuation compression. Trading at a trailing P/E of 29.11x, a significant premium to typical financial services stocks, IBKR is vulnerable to a derating if growth decelerates or if investor appetite for growth-at-a-price stocks wanes. Its beta of 1.322 confirms higher market correlation, meaning a broad market sell-off would likely hit IBKR harder. Competitively, while its low-cost, tech-driven model is a moat, the industry is subject to continuous regulatory change and disruptive fintech entrants, as highlighted by news on SEC rule changes benefiting rivals.

Worst-Case Scenario: The most damaging scenario would be a combination of a sharp decline in global trading volumes, a compression in net interest margins due to falling rates, and a subsequent earnings miss. This could trigger a simultaneous derating from its peak 29x P/E toward its historical low near 13x and a price decline toward its 52-week low of $49.15. A realistic severe downside from the current $81.35 would be a drop of approximately 35-40%, landing in the $50-$55 range, reflecting both earnings disappointment and multiple contraction.

FAQ

The key risks are: 1) Valuation Risk: The primary risk is multiple compression from its peak 29x P/E if growth decelerates, potentially leading to a 20-30% drawdown. 2) Operational Risk: Revenue is sensitive to market trading volumes and interest rates; a calm market or rate cuts could pressure the 13.6% growth rate. 3) Execution Risk: The recent Q1 revenue miss shows the market punishes any shortfall harshly at this valuation. 4) Market Risk: With a beta of 1.32, the stock is likely to fall more than the market in a broad sell-off. Valuation risk is currently the most severe given the stock's extended technical position.

Our 12-month forecast outlines three scenarios. The Base Case (60% probability) sees the stock trading between $80 and $90, as steady execution supports the current premium valuation. The Bull Case (25% probability) targets $95 to $105, requiring a breakout above all-time highs driven by accelerating growth and multiple expansion. The Bear Case (15% probability) warns of a drop to $55-$65 if growth stumbles and the P/E multiple contracts sharply. The Base Case is most likely, predicated on the assumption that IBKR can maintain its current growth and margin profile without further positive surprises.

IBKR is fairly valued to slightly overvalued relative to its own history, though the premium is justified by its superior fundamentals. The trailing P/E of 29.11x is at the top of its multi-year range (approx. 13x to 29x), indicating the market is paying a premium for past performance. Compared to the broader financial services sector, which often trades at lower multiples, IBKR's valuation is elevated. This implies the market expects the company to continue delivering low-teens revenue growth and maintain its elite profitability. Any stumble in growth could quickly make the stock look overvalued.

IBKR is a good stock for investors seeking exposure to a high-quality, efficiently-run global brokerage, but it is not an unequivocal 'buy' at current prices. The company's fundamentals are excellent, with 13.6% revenue growth, 87.5% operating margins, and a fortress balance sheet. However, the stock trades at a peak historical valuation of 29x P/E after a 57% yearly run, leaving limited margin for error. For a long-term investor willing to hold through volatility, initiating a small position or waiting for a pullback below $75 improves the risk/reward. It is less suitable for short-term traders or value-focused investors.

IBKR is more suitable for a long-term investment horizon of 3-5 years rather than short-term trading. Its business model benefits from the long-term secular trend of electronic trading and global market participation. However, its high beta of 1.322 and sensitivity to quarterly earnings make it volatile in the short term. Long-term investors can better weather this volatility and benefit from the company's compounding cash flows and market share gains. A minimum holding period of 18-24 months is suggested to allow the fundamental growth story to play out and overcome near-term valuation concerns.